Buscar
01/12/2021
Deciphering transplant outcomes of expanded kidney allografts donated after controlled circulatory death in the current transplant era. A call for caution
Montero, N, Toapanta, N, Pallares, N, Crespo, M, Diekmann, F, Guirado, L, Esteban, R, Codina, S, Melilli, E, Buxeda, A, Velis, G, Torres, IB, Revuelta, I, Andujar, AM, Facundo, C, Bardaji, B, Riera, L, Fiol, M, Cruzado, JM, Comas, J, Giral, M, Naesens, M, Asberg, A, Moreso, F, Bestard, O. Deciphering transplant outcomes of expanded kidney allografts donated after controlled circulatory death in the current transplant era. A call for caution. TRANSPLANT INTERNATIONAL. 2021; 34(12)DOI:10.1111/tri.14131. PMID:34626501. IF:3.842(Q1/3D).
01/12/2021
Long-term follow-up of renal function in patients treated with migalastat for Fabry disease (vol 28, 100786, 2021)
Bichet, DG, Torra, R, Wallace, E, Hughes, D, Giugliani, R, Skuban, N, Krusinska, E, Feldt-Rasmussen, U, Schiffmann, R, Nicholls, K. Long-term follow-up of renal function in patients treated with migalastat for Fabry disease (vol 28, 100786, 2021). Molecular Genetics and Metabolism Reports. 2021; 29DOI:10.1016/j.ymgmr.2021.100807. PMID:34934630. IF:2.082(Q4/9D).
01/12/2021
Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): report of 1640 cases from EUROAPS registry (vol 59, pg 1306, 2020)
Alijotas-Reig, J, Esteve-Valverde, E, Ferrer-Oliveras, R, Saez-Comet, L, Lefkou, E, Mekinian, A, Belizna, C, Ruffatti, A, Hoxha, A, Tincani, A, Nalli, C, Marozio, L, Maina, A, Espinosa, G, Rios-Garces, R, Cervera, R, De Carolis, S, Monteleone, G, Latino, O, Udry, S, Llurba, E, Garrido-Gimenez, C, Trespidi, L, Gerosa, M, Chighizola, CB, Rovere-Querini, P, Canti, V, Mayer-Pickel, K, Tabacco, S, Arnau, A, Trape, J, Ruiz-Hidalgo, D, Sos, L, Farran-Codina, I. Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): report of 1640 cases from EUROAPS registry (vol 59, pg 1306, 2020). RHEUMATOLOGY. 2021; 60(12)DOI:10.1093/rheumatology/keab659. PMID:34672326. IF:7.046(Q1/2D).
01/12/2021
Benefits and harms of breast cancer mammography screening for women at average risk of breast cancer: A systematic review for the European Commission Initiative on Breast Cancer
Canelo-Aybar, C, Ferreira, DS, Ballesteros, M, Posso, M, Montero, N, Sola, I, Saz-Parkinson, Z, Lerda, D, Rossi, PG, Duffy, SW, Follmann, M, Grawingholt, A, Alonso-Coello, P. Benefits and harms of breast cancer mammography screening for women at average risk of breast cancer: A systematic review for the European Commission Initiative on Breast Cancer. JOURNAL OF MEDICAL SCREENING. 2021; 28(4)DOI:10.1177/0969141321993866. PMID:33632023. IF:1.687(Q4/9D).